Literature DB >> 318820

Clinical effect of allopurinol on preserved kidneys: a randomized double-blind study.

L H Toledo-Pereyra, R L Simmons, L C Olson, J S Najarian.   

Abstract

We investigated the clinical posttransplant effect of allopurinol on preserved kidneys. Thirty-four paired kidneys from brain-dead cadavers were preserved by hypothermic pulsatile perfusion with silica gel fraction in separate cassettes. Allopurinol was added to one perfusate and omitted from the other in a randomized, double-blind, prospective plan. There was no difference in the short-term or long-term function of either group of kidneys. Allopurinol does not appear to have as consistent a beneficial effect on non-ischemically damaged human kidneys as that observed experimentally on ischemically damaged canine organs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 318820      PMCID: PMC1396251          DOI: 10.1097/00000658-197701000-00021

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  The lack of beneficial effect of allopurinol on renal preservation.

Authors:  M I Murdock; S I Cho
Journal:  Transplantation       Date:  1975-04       Impact factor: 4.939

2.  Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.

Authors:  M MERRELL; L E SHULMAN
Journal:  J Chronic Dis       Date:  1955-01

3.  Use of cellular membrane stabilizers to prevent ischemic damage to the kidneys.

Authors:  S N Chatterjee; T V Berne
Journal:  Surg Forum       Date:  1975

4.  Metabolic myocardial protection with allopurinol during cardiopulmonary bypass and aortic cross-clamping.

Authors:  W G Lindsay; L H Toledo-Pereyra; J E Foker; R L Varco
Journal:  Surg Forum       Date:  1975

5.  Allopurinol and hypoxanthine pretreatment of canine kidney donors.

Authors:  M L Owens; H M Lazarus; M W Wolcott; J G Maxwell; J B Taylor
Journal:  Transplantation       Date:  1974-04       Impact factor: 4.939

6.  A fibrinogen-free plasma perfusate for preservation of kidneys for one hundred and twenty hours.

Authors:  L H Toledo-Pereyra; R M Condie; R Malmberg; R L Simmons; J S Najarian
Journal:  Surg Gynecol Obstet       Date:  1974-06

7.  Simplification of organ preservation techniques: experimental and clinical experience.

Authors:  A W Moberg; M F Mozes; R A Campos; E A Santiago; J S Najarian
Journal:  Transplant Proc       Date:  1972-12       Impact factor: 1.066

8.  Comparative effects of chlorpromazine, methylprednisolone, and allopurinol during small bowel preservation.

Authors:  L H Toledo-Pereyra; R L Simmons; J S Najarian
Journal:  Am J Surg       Date:  1973-11       Impact factor: 2.565

9.  Responses of the ischemic myocardium to allopurinol.

Authors:  R A DeWall; K A Vasko; E L Stanley; P Kezdi
Journal:  Am Heart J       Date:  1971-09       Impact factor: 4.749

10.  Proceedings: the effect of allopurinol in sparing ATP, ADP, and AMP in anoxic kidneys.

Authors:  T V Keaveny; S K Cunningham; P FitzGerald
Journal:  Br J Surg       Date:  1973-11       Impact factor: 6.939

View more
  3 in total

1.  Management of acute renal failure in children.

Authors:  N J Siegel
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

Review 2.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

3.  Oxygen free radicals in ischemic acute renal failure in the rat.

Authors:  M S Paller; J R Hoidal; T F Ferris
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.